UBS Group’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
BFIM
HNB
UBS Group's DBD Position: Q2 2023 in Review
UBS Group sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 280,745 shares — an estimated $337K sold.
UBS Group first reported a position in DBD in Q4 2014 and held it in 34 quarters. The position peaked at $6.27M in Q1 2018. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.
- UBS Group reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 280,745 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $337K.
- UBS Group first reported a position in Diebold Nixdorf Incorporated in Q4 2014 and held it in 34 quarters.
- UBS Group's Diebold Nixdorf Incorporated position peaked at $6.27M in Q1 2018.
- 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.